Vertex Pharmaceuticals trades on Nasdaq, files reports with the SEC, and has an executive named Duncan McKechnie.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vertex Pharmaceuticals trades on Nasdaq, files reports with the SEC, and has an executive named Duncan McKechnie.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Vertex Pharmaceuticals
American pharmaceutical company
Related events
- Goldman Sachs updated its top stock picks, removing Interactive Brokers and adding Vertex Pharmaceuticals.
- Vertex Pharmaceuticals CEO leads the company's strategic business direction.
- Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.
- Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.